Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Original Research
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,322 | Dovepress* | 3,058+ | 87 | 3,145 | |
| PubMed Central* | 264 | 127 | 391 | ||
| Totals | 3,322 | 214 | 3,536 | ||
| *Since 27 February 2023 | |||||
View citations on PubMed and Google Scholar